3'-epimeric K-252A derivatives

Details 3'-epimeric K-252A derivatives 3'-epimeric K-252A derivatives

1998-12-30

2000-07-25

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514213, 540543, 540546, A61K 3155, C07D49822

Patent

active

060937130

ABSTRACT:
Compounds defined by the following general structure are disclosed: ##STR1## These compounds display pharmacological activities, including inhibition of tyrosine kinase activity and enhancement of the function and/or survival of trophic factor responsive cells, e.g., cholinergic neurons.

REFERENCES:
patent: 5461146 (1995-10-01), Lewis et al.
patent: 5468872 (1995-11-01), Glicksman et al.
patent: 5516772 (1996-05-01), Glicksman et al.
patent: 5585488 (1996-12-01), Kinugawa et al.
patent: 5621100 (1997-04-01), Lewis et al.
Kaneko et al., J. Med. Chem. 1997, 40, pp. 1863-1869.
Kinugawa, M. et al., "Synthetic Process Development of Antitumor Agent KT6587, an Indolocarbazole Alkaloid K252a Derivative, " Org. Proc. Res. Devel., 1999, 3, 131-134.
Nakanishi, S. et al., "K-252b, c and d, potent inhibitors of protein Kinase C from microbial origin," J. Antibiotics, 1986, vol. XXXIX(8), 1066-1071.
Sezaki, M. et al., "A new antibiotic SF-2370 produced by actinomadura," J. Abtibiotics, 1985, vol. XXXVIII(10), 1437-1439.

Affiliated with

Also associated with

Rating

3'-epimeric K-252A derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3'-epimeric K-252A derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3'-epimeric K-252A derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1336776